May 8 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH PROVIDES UPDATE ON ITS CHRONIC COUGH DRUG CANDIDATE BLU-5937 AND REPORTS FINANCIAL AND OPERATING RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2019
* BELLUS HEALTH INC - COMPANY CONCLUDED QUARTER WITH CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS TOTALLING $45.4 MILLION
* BELLUS HEALTH INC - HAS ENOUGH CAPITAL TO FUND ITS OPERATIONS INTO Q1 2021
* BELLUS HEALTH INC - QTRLY LOSS PER SHARE $0.03